Preventing a hypereosinophilic syndrome (HES) flare centers on keeping your eosinophil count low and stable through consistent medication, regular blood monitoring, and awareness of your personal triggers. HES is defined by an eosinophil count above 1,500 cells per microliter of blood persisting for six months or longer, with evidence of organ damage. The goal of prevention is to keep that count well below the threshold where eosinophils begin harming your heart, lungs, skin, or nervous system.
How HES Flares Happen
A flare occurs when your eosinophil count surges and these white blood cells begin infiltrating tissues, causing inflammation and damage. The organs most commonly affected are the heart, skin, lungs, and gastrointestinal tract. Over time, repeated flares can lead to permanent scarring, particularly in heart tissue. Because eosinophil levels can rise before you feel symptoms, prevention depends heavily on proactive monitoring rather than waiting for problems to appear.
Medications That Keep Eosinophils in Check
Corticosteroids are the first-line treatment for most forms of HES. They work quickly, and most patients see their eosinophil count drop within one to two days of starting therapy. For long-term prevention, the strategy is finding the lowest effective dose that keeps your count stable, since prolonged steroid use carries its own risks: bone thinning, weight gain, blood sugar changes, and immune suppression.
When steroids alone aren’t enough, or when side effects become a problem, a second medication is typically added. The two most commonly used options each work in roughly 30% of patients. For a specific subtype called lymphocytic-variant HES, where abnormal immune cells drive eosinophil production, interferon-alpha is preferred because it targets both the eosinophils and the T cells fueling them.
Biologic Therapies
Mepolizumab (brand name Nucala) is FDA-approved specifically for HES in patients aged 12 and older who have had the condition for at least six months without an identifiable secondary cause. It’s given as three subcutaneous injections (totaling 300 mg) once every four weeks. Mepolizumab works by blocking interleukin-5, a signaling molecule that tells your body to produce and activate eosinophils. To qualify, patients typically need to have experienced at least two flares in the prior year with an eosinophil count of 1,000 cells per microliter or higher.
A newer option, benralizumab, showed strong results in the phase 3 NATRON trial. Patients receiving benralizumab in addition to their existing HES therapy had a 65% reduction in the risk of their first flare compared to placebo. Only 22.4% of patients on benralizumab experienced a flare, versus 45.5% on placebo. The annualized flare rate dropped from 1.23 per year to 0.41. Benralizumab works by targeting the receptor that interleukin-5 binds to, causing near-complete depletion of eosinophils.
Blood Monitoring Is Non-Negotiable
Regular blood tests to check your absolute eosinophil count (AEC) are the cornerstone of flare prevention. Even if you feel fine, a rising count signals trouble before symptoms appear. For patients with stable, well-controlled HES, blood checks at least every three months are recommended for the first one to two years. Your doctor may adjust this schedule based on how your count behaves over time.
There’s no single “safe” number that applies to everyone, but treatment success is generally measured by keeping eosinophils well below the 1,500 cells/mcL threshold. Some patients on biologic therapy maintain counts between 200 and 450 cells/mcL. Extremely high counts (above 100,000 cells/mcL), signs of heart failure, features of a bone marrow disorder, or resistance to steroids are all associated with more aggressive disease and poorer outcomes.
Know Your Triggers
Several conditions can cause eosinophil surges and trigger or worsen HES flares:
- Parasitic or bacterial infections: These naturally activate eosinophils as part of the immune response. Even a mild infection can push already-elevated counts into dangerous territory.
- Allergic reactions: Seasonal allergies, food allergies, or environmental exposures can stimulate eosinophil production.
- Drug reactions: Certain medications provoke eosinophilia as a side effect. If you notice a flare pattern after starting a new medication, report it promptly.
- Chronic inflammatory conditions: Autoimmune disorders or long-standing inflammatory diseases can keep your immune system in a state of activation that feeds eosinophil production.
Keeping a log of your flares alongside any infections, new medications, dietary changes, or allergy exposures can help you and your doctor identify patterns specific to your case.
Diet and Lifestyle Factors
There is no HES-specific diet proven to prevent flares, but the connection between allergic inflammation and eosinophils suggests that reducing allergen exposure could help some patients. Animal studies have shown that dietary restriction can suppress inflammatory cell infiltration (including eosinophils) in tissues, and small human studies have linked plant-based diets with reduced peripheral eosinophil counts in patients with allergic skin conditions.
If food allergies are part of your clinical picture, working with an allergist to identify and eliminate specific triggers may help stabilize your baseline eosinophil levels. This is most relevant for patients whose HES overlaps with eosinophilic gastrointestinal disorders. For everyone else, general anti-inflammatory habits like maintaining a healthy weight, managing stress, and avoiding known allergens are reasonable but shouldn’t replace medication.
Recognizing Early Warning Signs
Catching a flare early gives you the best chance of preventing organ damage. The specific symptoms depend on which organs your eosinophils tend to target, but common warning signs include new or worsening skin rashes, shortness of breath, cough, chest tightness, fatigue, fever, and muscle aches. Gastrointestinal symptoms like abdominal pain or diarrhea can also signal rising eosinophil activity.
If your HES affects your heart, pay particular attention to swelling in your legs, difficulty breathing when lying flat, or unusual fatigue during routine activity. Cardiac involvement is one of the most serious complications of HES, as eosinophils can cause scarring of the heart muscle over time. Having a written action plan that specifies which symptoms should prompt an urgent blood draw, a steroid dose adjustment, or an emergency visit makes it easier to act quickly rather than second-guess yourself during a flare.
Protecting Against Organ Damage Long-Term
Prevention isn’t only about avoiding flares. It’s also about minimizing the cumulative damage that eosinophils cause between flares if counts remain even mildly elevated. Baseline assessments of your heart (typically with an echocardiogram), lungs, and other commonly affected organs give your care team a reference point to detect early changes. Repeat imaging at regular intervals can catch fibrosis or other structural damage before it becomes symptomatic.
The most important long-term strategy is medication adherence. Skipping doses of a biologic or tapering steroids too quickly are common causes of preventable flares. If side effects are making it hard to stick with your treatment plan, that’s a signal to discuss steroid-sparing options rather than reduce treatment on your own. With consistent monitoring and the expanding range of biologic therapies now available, most HES patients can achieve stable eosinophil counts and significantly reduce their flare frequency.